Delivery Order SPE2DB22D3004-SPE2DB24FQE57

Award Date 4/30/24
Potential Completion Date 5/1/24
Potential Value $24K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order for 4,563,881,285 units of Meloxicam 15 mg tablets, valued at $1,678.96, with a performance period through March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Meloxicam 15 mg tablets in 1,000-count units. The $88,237.45 firm fixed-price delivery order has an ultimate completion date of December 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $47,225.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,027,993 units of Meloxicam 15 mg tablets, with an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,660,909 units of the pharmaceutical product Meloxicam 15 mg Tablet in 180s packages. The $4,362.32 firm fixed-price contract was awarded on May 20, 2024 by the Defense Logistics Agency (DLA), with a completion date of May 21, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,419.24 firm fixed price delivery order is for the supply of 4,566,661,486 units of the medication Meloxicam 15 mg Tablet, with a completion date of December 10, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,023.67 firm-fixed-price delivery order is for the supply of 4,566,613,832 units of the generic drug Meloxicam 15 mg tablets. The contract has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of 4,567,249,098 units of the prescription medication Meloxicam 15 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $94,406.61 and a performance period through February 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $29,074.33 firm fixed price delivery order is for the supply of 180 tablets of the prescription medication Meloxicam 15 mg. The contract has an ultimate completion date of May 10, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FPH40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $45,412.58, is for the delivery of meloxicam 15 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FPJ88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 tablets of the medication Meloxicam 15 mg, with a ceiling value of $4,978.00 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is a delivery order under a larger...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FQE57
    Delivery Order

This federal contract award, with the ID SPE2DB22D3004|SPE2DB24FQE57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $23,877.92 firm fixed-price delivery order is for 4,564,451,649 units of the medication Meloxicam 15 mg Tablets in 180-count bottles.

The award is not associated with any set-aside designation and has an ultimate completion date of May 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 7/30/24, 9:24 AM